Grifols Closes with a 5.35% Increase in Its Key Week Due to Deadline for Reporting to CNMV

Madrid, Spain - Images from the Madrid Stock Exchange, where Grifols' shares closed Monday's session with a rise of over 5% in a crucial week for the plasma-derived products company due to the deadline for submitting detailed information to the National Securities Market Commission (CNMV) on various aspects of its accounting, including the links of Grifols with the company Scranton.